TAMPA, Fla. — Dermatologists are urging you to check your skin today for Melanoma Monday, an annual reminder of the dangers of melanoma and the importance of early detection and treatment. “I ...

BioNTech chalks up an important win in its cancer pipeline, showing efficacy with its BNT111 vaccine in a phase 2 trial in melanoma.

Bristol Myers Squibb has reported disappointing results for its checkpoint inhibitor combination Opdualag in an adjuvant melanoma study.